Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.

Chan AC, Chok KS, Yuen WK, Chan SC, Poon RT, Lo CM, Fan ST.

Arch Surg. 2011 Jun;146(6):675-81. doi: 10.1001/archsurg.2011.125.

PMID:
21690443
2.

HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.

Hosaka T, Suzuki F, Kobayashi M, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H.

Liver Int. 2010 Nov;30(10):1461-70. doi: 10.1111/j.1478-3231.2010.02344.x. Epub 2010 Sep 14.

PMID:
20840396
3.

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.

Kuzuya T, Katano Y, Kumada T, Toyoda H, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Honda T, Goto H.

J Gastroenterol Hepatol. 2007 Nov;22(11):1929-35.

PMID:
17914972
4.

Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.

Jin YJ, Shim JH, Lee HC, Yoo DJ, Kim KM, Lim YS, Suh DJ.

J Gastroenterol Hepatol. 2011 Sep;26(9):1380-8. doi: 10.1111/j.1440-1746.2011.06776.x.

PMID:
21884247
5.

Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.

Zhang ZY, Zhou ZQ, Zhou GW.

Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1116-24. doi: 10.1097/MEG.0000000000000153.

PMID:
25003747
6.

A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.

Li N, Lai EC, Shi J, Guo WX, Xue J, Huang B, Lau WY, Wu MC, Cheng SQ.

Ann Surg Oncol. 2010 Jan;17(1):179-85. doi: 10.1245/s10434-009-0694-z. Epub 2009 Aug 29.

PMID:
19727956
7.

High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.

Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, Shen F, Wu MC.

Eur J Surg Oncol. 2012 Aug;38(8):683-91. doi: 10.1016/j.ejso.2012.04.010. Epub 2012 May 22.

PMID:
22621971
8.

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.

Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW.

Liver Transpl. 2009 Nov;15(11):1525-34. doi: 10.1002/lt.21882.

10.

Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load.

Huang G, Yang Y, Shen F, Pan ZY, Fu SY, Lau WY, Zhou WP, Wu MC.

Ann Surg Oncol. 2013 May;20(5):1482-90. doi: 10.1245/s10434-012-2803-7. Epub 2012 Dec 18.

PMID:
23247982
11.

Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues.

Toyoda H, Kumada T, Tada T, Sone Y, Fujimori M.

J Vasc Interv Radiol. 2012 Mar;23(3):317-22.e1. doi: 10.1016/j.jvir.2011.11.012. Epub 2012 Jan 21.

PMID:
22265248
12.

Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.

Cescon M, Cucchetti A, Grazi GL, Ferrero A, ViganĂ² L, Ercolani G, Ravaioli M, Zanello M, Andreone P, Capussotti L, Pinna AD.

Arch Surg. 2009 Oct;144(10):906-13. doi: 10.1001/archsurg.2009.99.

PMID:
19841357
13.

How does hepatitis B virus infection react to hepatocellular carcinoma treatment?

Wong GL.

J Gastroenterol Hepatol. 2012 Jan;27(1):1-2. doi: 10.1111/j.1440-1746.2011.06950.x. No abstract available.

PMID:
22188022
14.

Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study.

Yin J, Li N, Han Y, Xue J, Deng Y, Shi J, Guo W, Zhang H, Wang H, Cheng S, Cao G.

J Clin Oncol. 2013 Oct 10;31(29):3647-55. doi: 10.1200/JCO.2012.48.5896. Epub 2013 Sep 3. Erratum in: J Clin Oncol. 2013 Nov 10;31(32):4167. J Clin Oncol. 2014 May 1;32(13):1386-7.

PMID:
24002499
15.

Quiet reflection after effective action: hepatitis B viraemia and hepatocellular carcinoma recurrence.

Abdo AA, Sanai FM.

Liver Int. 2008 Apr;28(4):423-5. doi: 10.1111/j.1478-3231.2008.01731.x. No abstract available.

PMID:
18339067
16.

Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.

An HJ, Jang JW, Bae SH, Choi JY, Cho SH, Yoon SK, Han JY, Lee KH, Kim DG, Jung ES.

J Gastroenterol Hepatol. 2010 Dec;25(12):1876-82. doi: 10.1111/j.1440-1746.2010.06416.x.

PMID:
21092000
17.

LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.

Zhou L, Rui JA, Wang SB, Chen SG, Qu Q.

J Surg Res. 2010 Mar;159(1):538-44. doi: 10.1016/j.jss.2008.09.004. Epub 2008 Oct 7.

PMID:
19111323
18.

Hepatitis B virus DNA and hepatocellular carcinoma recurrence after resection: the lower, the better!

You H, Jia JD.

J Gastroenterol Hepatol. 2010 Dec;25(12):1812-4. doi: 10.1111/j.1440-1746.2010.06516.x. No abstract available.

PMID:
21091989
19.

Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma.

Huang S, Xia Y, Lei Z, Zou Q, Li J, Yang T, Wang K, Yan Z, Wan X, Shen F.

J Am Coll Surg. 2017 Mar;224(3):283-293.e4. doi: 10.1016/j.jamcollsurg.2016.11.009. Epub 2016 Dec 5.

PMID:
27923614
20.

Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.

Dan JQ, Zhang YJ, Huang JT, Chen MS, Gao HJ, Peng ZW, Xu L, Lau WY.

Eur J Surg Oncol. 2013 Aug;39(8):865-72. doi: 10.1016/j.ejso.2013.03.020. Epub 2013 Apr 15.

PMID:
23597497

Supplemental Content

Support Center